Immune Signaling Research
Thymosin Alpha-1
BioHarmony verdict
Strong recommend
Thymosin Alpha-1 is a 28-amino-acid thymic peptide with strongest evidence in immune-compromised and hospital-adjacent settings: Cao 2024 pooled 39 acute COPD exacerbation RCTs, while TESTS 2025 found no clear 28-day sepsis mortality benefit.
Read full reportWhat is Thymosin Alpha-1?
Thymosin Alpha-1, also called thymalfasin or TA-1, is a 28-amino-acid thymic peptide used internationally as Zadaxin and in the United States through non-FDA-approved peptide channels. Its core role is immune modulation: TA-1 helps dendritic cells bridge innate and adaptive immunity, nudges T-helper signaling toward antiviral Th1 activity, supports CD4/CD8 recovery in lymphopenic states, and may improve monocyte HLA-DR expression in sepsis-induced immune suppression.
From the BioHarmony report, reviewed 2026-09-08.
How it is thought to work
TLR9 and TLR2 signaling on dendritic cells, NF-kB activation, Th1 polarization, CD4/CD8 normalization, NK-cell support, and IDO-mediated immune tolerance.
Safety watch-outs
- Injection-site infection
- Autoimmune flare symptoms
Full risk profile in the BioHarmony report.
Dosing as published
No approved-label or study protocol is recorded for Thymosin Alpha-1 yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (4)
Attributed viewpoints, separate from primary research.
- International Peptide Society 2018 Compound CurriculumDr. William Seeds · 2018-07-20
- Peptides to Promote Cellular HealthDr. Suzanne Ferree · 2025-09-15
- Thymosin Alpha-1: 2025 Update on My Favorite Immune PeptideHunter Williams · 2026-03-30
- Thymosin Alpha 1 vs Thymosin Beta 4: Key DifferencesJay Campbell · 2026-05-19
Trust & sourcing
Primary sources
Sources are still being reviewed for this compound.
Related peptides for recovery & tissue repair
Free guide
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.